articleTop 1% cited
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
Schizophrenia Research · 2003 · Vol. 61(2-3) · pp. 123–136
Stephen R. Marder✉(University of California, Los Angeles)Robert D. McQuade(Bristol-Myers Squibb (United States))Elyse Stock(Bristol-Myers Squibb (United States))Stephen Kaplita(Bristol-Myers Squibb (United States))Ronald N. Marcus(Bristol-Myers Squibb (Germany))Allan Z. Safferman(Bristol-Myers Squibb (Germany))Anutosh Ranjan Saha(Otsuka (United States))Mirza W. Ali(Otsuka (United States))Taro Iwamoto(Otsuka (Japan))
Schizophrenia research and treatmentBipolar Disorder and TreatmentDiabetes Treatment and ManagementAripiprazoleAkathisiaTolerabilityHaloperidolPlaceboPositive and Negative Syndrome ScaleAntipsychoticExtrapyramidal symptomsPsychologyAtypical antipsychotic
MeSH terms
AripiprazoleAcute DiseaseAdultDouble-Blind MethodFemaleHaloperidolHumansMaleMiddle AgedPiperazinesPsychotic DisordersSchizophreniaSchizophrenic PsychologyAntipsychotic AgentsMulticenter Studies as Topic
Funding
- Bristol-Myers Squibb
- Otsuka Pharmaceutical
Citations
469
FWCI
23.78
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs
Neuropsychopharmacology · 2003 · 789 citations
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
Molecular Psychiatry · 2004 · 974 citations
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Neuropsychopharmacology · 2003 · 967 citations
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Schizophrenia Bulletin · 2004 · 765 citations
References
Olanzapine versus Placebo and Haloperidol
Neuropsychopharmacology · 1996 · 785 citations
Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
Journal of Pharmacology and Experimental Therapeutics · 2002 · 915 citations
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
European Journal of Pharmacology · 2002 · 505 citations
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
Schizophrenia Research · 1999 · 802 citations
The unhealthy lifestyle of people with schizophrenia
Psychological Medicine · 1999 · 884 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.